Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
3
38%
Ph phase_1
3
38%
Ph phase_4
2
25%

Phase Distribution

3

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 4Post-market surveillance
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (37.5%)
Phase 23 (37.5%)
Phase 42 (25.0%)

Trials by Status

terminated113%
unknown113%
completed675%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_1

Recombinant Human Serum Albumin in Healthy Subjects

NCT05179265
completedphase_1

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

NCT05249374
completedphase_2

Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

NCT06553456
completedphase_2

Phase II/III of Recombinant Human Serum Albumin

NCT05858853
completedphase_1

Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）

NCT04992832
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05179265Phase 1

Recombinant Human Serum Albumin in Healthy Subjects

Completed
NCT05249374Phase 1

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

Completed
NCT06553456Phase 2

Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

Completed
NCT05858853Phase 2

Phase II/III of Recombinant Human Serum Albumin

Completed
NCT04992832Phase 1

Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）

Completed
NCT01553617Phase 4

VolulyteTM in Cardiac Surgery

Completed
NCT01689506Phase 4

Fluid Resuscitation in Patients Suffering From Burns Injury

Terminated
NCT00152685Phase 2

High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8